PARAGON CAPITAL MANAGEMENT INC RPRX ROYALTY PHARMA PLC

Ownership history in PARAGON CAPITAL MANAGEMENT INC  ·  6 quarters on record

AI Ownership Summary

PARAGON CAPITAL MANAGEMENT INC reported ROYALTY PHARMA PLC (RPRX) in 6 quarterly 13F filings from 2024 Q3 through 2025 Q4. Peak portfolio weight reached 1.41% in 2025 Q2. The latest visible filing shows RPRX at 1.32% of the fund.

This page tracks quarterly shares, estimated market value, portfolio weight, filing dates, and disclosure-aligned stock prices directly from SEC EDGAR 13F filings.

What this RPRX ownership page tells you

This page is designed to answer the real investor question behind a 13F filing: how meaningful was PARAGON CAPITAL MANAGEMENT INC's position in ROYALTY PHARMA PLC, and how did that conviction change over time? You can read the holding window, peak weight, latest reported size, disclosure timing, and quarter-by-quarter changes without piecing the story together from raw SEC rows.

Freshest filing
Latest Reported Filing
2025 Q4

RPRX was reported at 1.32% of portfolio in the most recent visible filing.

High-water mark
Peak Conviction
1.41% in 2025 Q2

Peak weight helps separate a token disclosure from a real conviction holding the fund genuinely cared about.

Time in book
Holding Window
2024 Q3 to 2025 Q4

Longer holding windows often tell a very different story from short-lived tactical trades or one-quarter experiments.

Decision context
Why It Matters
Position size beats headlines

Knowing that a fund owned a stock is useful. Knowing whether it was a 0.20% placeholder or a true high-conviction position is where the signal actually starts.

How PARAGON CAPITAL MANAGEMENT INC held RPRX — position size vs. price
% of Fund (quarterly)    RPRX price (quarter-end, indexed to 100)    SPY (indexed to 100)    QQQ (indexed to 100)
📋 Quarterly Holdings History 6 quarters  
Quarter Action Sold % After 3M Timing Shares Change Chg % % of Fund Mkt Value Filed Price (Filed)
2025 Q4 REDUCED 10.2% +24.8% 44,254 -5,033 -10.2% 1.32% $1.7M 2026-01-23 $40.19
2025 Q3 REDUCED 49,287 -2,120 -4.1% 1.30% $1.7M 2025-10-15 $35.79
2025 Q2 REDUCED 51,407 -902 -1.7% 1.41% $1.9M 2025-08-06 $36.50
2025 Q1 REDUCED 25.6% +16.5% 52,309 -18,030 -25.6% 1.32% $1.6M 2025-04-24 $31.29
2024 Q4 ADDED 70,339 +53,937 +328.8% 1.40% $1.8M 2025-01-27 $30.78
2024 Q3 INITIATED 16,402 0.34% $464K 2024-10-16 $27.16

FAQ About PARAGON CAPITAL MANAGEMENT INC and RPRX

These are the practical questions this page is built to answer before you even open the full history table.

How long has PARAGON CAPITAL MANAGEMENT INC reported owning RPRX?

PARAGON CAPITAL MANAGEMENT INC reported RPRX across 6 quarterly 13F filings, from 2024 Q3 through 2025 Q4.

What was the largest reported RPRX position in PARAGON CAPITAL MANAGEMENT INC's portfolio?

The largest reported portfolio weight for RPRX was 1.41% in 2025 Q2.

What is the latest reported RPRX position on this page?

The most recent filing on this page is 2025 Q4, when PARAGON CAPITAL MANAGEMENT INC reported 44,254 shares, equal to 1.32% of portfolio, with an estimated market value of $1.7M.

What does the chart on this RPRX ownership page compare?

The chart compares PARAGON CAPITAL MANAGEMENT INC's quarterly RPRX portfolio weight with the stock's indexed share price, so you can see whether the fund was building, trimming, or holding the position as price moved.

How well did PARAGON CAPITAL MANAGEMENT INC time their RPRX position?

Based on 13F filing dates vs. subsequent RPRX price moves, PARAGON CAPITAL MANAGEMENT INC correctly timed 3 out of 5 reported position changes (60%). The annualised alpha on RPRX relative to SPY over the holding period was +17.8%.

← Back to PARAGON CAPITAL MANAGEMENT INC Holdings